经尿道等离子前列腺剜除术和电切术治疗前列腺增生的疗效差异分析

目的:探讨分析经尿道等离子前列腺剜除术和电切术治疗前列腺增生的疗效差异。方法:选取2014年10月至2015年10月期间来我院就诊并接收治疗的前列腺增生患者90例,随机将其分为对照组和观察组,每组45例。对照组患者给予经尿道等离子前列腺电切术治疗,观察组患者给予经尿道等离子前列腺剜除术治疗,术后定期随访,对两组患者的临床治疗效果、手术时间、术中出血量、前列腺切除量、尿管停留时间、术后并发症发生率以及患者预后的最大残余尿量、前列腺症状评分、生活质量评分、最大尿流率等进行分析对比。结果:观察组患者的临床治疗总有效率为97.8%,显著性高于对照组(84.4%)(P0.05);观察组患者的手术时间、术中出血量、尿管停留时间均显著性低于对照组(P0.05),观察组患者的前列腺切除量显著性高于对照组(P0.05),观察组患者的总并发症发生率为8.9%,显著性低于对照组(26.7%)(P0.05);两组患者术后的残余尿量、前列腺症状评分、生活质量评分、最大尿流率较术前比较均有显著的改善(均P0.05),但两组间的差异无统计学意义(P0.05)。结论:经尿道等离子前列腺剜除术和电切术治疗前列腺增生都能起到良好的远期治疗效果,但经尿道等离子前列腺剜除术的临床治疗效果更显著、安全性更好,值得临床进一步推广使用。

Efficacy analysis of bipolar plasmakinetic resection of prostate and bipolar plasmakinetic enucleation of prostate for benign prostatic hyperplasia

Objectives:To investigate the efficacy of bipolar plasmakinetic resection of prostate and bipolar plasmakinetic enucleation of prostate for benign prostatic hyperplasia.Methods:90 patients with benign prostatic hyperplasia treated in our hospital from October 2014 to October 2015 were selected and randomly divided into control group and observation group,with 45 cases in each group.Patients in control group were given bipolar plasmakinetic resection of prostate for treatment,while the patients in observation group were given bipolar plasmakinetic enucleation of prostate for treatment.All patients were followed up regularly after surgery.The clinical outcomes,operative time,blood loss,weight of resection of the prostate,catheter dwell time,complication rates and the prognosis of RUV,IPSS,QOL,and Qmax were compared between the two groups.Results:The total clinical efficiency of observation group was 97.8％,which was significantly higher than that of control group (84.4％),(P ＜ 0.05).The operative time,blood loss and catheter dwell time in observation group were all significantly lower than these in control group (all P ＜ 0.05).The weight of resection of the prostate in observation group was significantly higher than that in control group (P ＜ 0.05).The complication rate of observation group was 8.9％,which was significantly lower than that of control group (26.7％),(P ＜0.05).The RUV,IPSS,QOL and Qmax in the two groups were all significantly improved compared with these before the treatment (all P ＜ 0.05),but the differences between two groups were not statistically significant (P ＞ 0.05).Conclusion:For patients with benign prostatic hyperplasia,bipolar plasmakinetic resection of prostate and bipolar plasmakinetic enucleation of prostate can achieve long-term treatment efficiency,the latter with better security,which is worth further clinical application.